By The Registry Staff The biotech sector has long been a roller coaster of financial highs and lows, reflecting the high-risk, high-reward nature of pioneering new treatments. Sangamo Therapeutics Inc.'s recent decision to leave its Brisbane location is emblematic of the industry's broader challenges, especially from a real estate standpoint. Sangamo's announcement that it will […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Fairfield Residential, the San Diego-based apartment investor majority-owned by the California State...
ByThe RegistryNovember 17, 2026Aluminum-fuel startup Voya Energy is consolidating its corporate and technical teams into...
ByThe RegistryNovember 17, 2026Nuveen Real Estate has taken control of a 13-property open-air retail portfolio...
ByThe RegistryNovember 17, 2026Valley Water and its federal, state and city partners have finished the...
ByThe RegistryNovember 17, 2026